Skip to main content Accessibility help
×
×
Home

The straw man of prescribing in psychiatry: Commentary on… drug-centred psychopharmacology

  • David Taylor

Summary

‘Drug-centred’ prescribing in psychiatry has been proposed as a new and better approach than the current ‘disease-centred’ alternative. It targets symptoms most important to the patient using the concept that psychotropics act indirectly by altering normal functioning. I contend that it is a straw man: psychiatrists already use ‘drug-centred’ prescribing, applying their knowledge of a drug's pharmacological profile and evidence base to treat each patient's symptoms, not their diagnostic classification. Furthermore, there is no compelling evidence that psychotropics act by altering ‘normal’ functioning: rather, they have diverse effects on different mental states.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The straw man of prescribing in psychiatry
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The straw man of prescribing in psychiatry
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The straw man of prescribing in psychiatry
      Available formats
      ×

Copyright

Corresponding author

Professor David Taylor, Pharmacy Department, Maudsley Hospital, Denmark Hill, London SE5 8AZ, UK. Email: david.taylor@slam.nhs.uk

Footnotes

Hide All

DECLARATION OF INTEREST

Advisory Board member for: Lundbeck, Servier, Sunovion; lectures for Janssen, Lundbeck, Otsuka, Servier: research funding from: BMS, Janssen, Lundbeck

See pp. 229–236, this issue.

Footnotes

References

Hide All
Akiskal, HS, Bourgeois, ML, Angst, J et al (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. Journal of Affective Disorders, 59 (suppl 1): S530.
Berman, RM, Fava, M, Thase, ME et al (2009) Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectrums, 14: 197206.
Emsley, R, Chiliza, B, Asmal, L et al (2014) A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia. Schizophrenia Research, 158: 230–35.
Fisher, DS, Handley, SA, Flanagan, RJ et al (2012) Plasma concentrations of quetiapine, N-desalkylquetiapine, o-desalkylquetiapine, 7-hydroxy-quetiapine, and quetiapine sulfoxide in relation to quetiapine dose, formulation, and other factors. Therapeutic Drug Monitoring, 34: 415–21.
Frogley, C, Anagnostakis, K, Mitchell, S et al (2013) A case series of clozapine for borderline personality disorder. Annals of Clinical Psychiatry, 25: 125–34.
Hough, D, Gopal, S, Vijapurkar, U et al (2010) Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophrenia Research, 116: 107–17.
Kane, J, Honigfeld, G, Singer, J et al (1988) Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45: 789–96.
Kane, JM, Sanchez, R, Perry, PP et al (2012) Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 73: 617–24.
Mezhebovsky, I, Magi, K, She, F et al (2013) Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder. International Journal of Geriatric Psychiatry, 28: 615–25.
Suppes, T, Webb, A, Paul, B et al (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. American Journal of Psychiatry, 156: 1164–69.
Taylor, DM, Cornelius, V, Smith, L et al (2014) Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta Psychiatrica Scandinavica, 130: 452–69.
Taylor, D, Paton, C, Kapur, S (2015) Maudsley Prescribing Guidelines in Psychiatry (12th edn). Wiley-Blackwell.
Wunderink, L, Nieboer, RM, Wiersma, D et al (2013) Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70: 913–20.
Yeomans, D, Moncrieff, J, Huws, R (2015) Drug-centred psychopharmacology: a non-diagnostic framework for drug treatment. BJPsych Advances, 21: 229–36.
Zohar, J, Stahl, S, Moller, H-J et al (2014) Neuroscience-Based Nomenclature. Cambridge University Press.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 2056-4678
  • EISSN: 2056-4686
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

The straw man of prescribing in psychiatry: Commentary on… drug-centred psychopharmacology

  • David Taylor
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *